Phase II Magnetic Alteration of Pectus Excavatum
The Magnetic Mini-Mover Procedure (3MP) represents a novel approach to treating pectus excavatum, a prevalent congenital chest wall deformity. The market for pectus excavatum treatments is primarily composed of surgical interventions, which can be invasive and carry significant risks. This non-invasive alternative could appeal to parents and patients seeking less traumatic options. Given the limited competition in non-surgical treatments for this condition, successful outcomes could position UCSF as a leader in pediatric chest wall deformity corrections. However, the commercial viability will depend on the robustness of clinical data, regulatory pathways, and potential reimbursement strategies. Diligence should focus on the long-term efficacy and safety data, as well as the potential for broader applications of magnetic therapies in other deformities.
Indication: Pectus Excavatum
Modality: medical device
Target: Magnetic field application for gradual correction of pectus excavatum deformity via biologic reformation of cartilage.
Sponsor: University of California, San Francisco
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 21, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Magnetic field application for gradual correction of pectus excavatum deformity via biologic reformation of cartilage.
View original source fields
Condition raw: Pectus Excavatum
Condition normalized: Pectus Excavatum
Modality raw: medical device
Modality normalized: medical device
Target raw: Magnetic field application for gradual correction of pectus excavatum deformity via biologic reformation of cartilage.
Target normalized: Magnetic field application for gradual correction of pectus excavatum deformity via biologic reformation of cartilage.